Stockreport

FDA Accepts GSK's Filing for Expanded Use of Nucala in COPD [Yahoo! Finance]

Alnylam Pharmaceuticals, Inc.  (ALNY) 
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.alnylam.com/investor-overview
PDF A decision from the regulatory body is expected on May 7, 2025. GSK's Nucala is a monoclonal antibody with a novel mechanism of action that targets IL-5, a key messeng [Read more]